AFP and neoplasm: However, a strategy led by one single diagnostic modality will always run the risk of serial false-negative findings, and this setting provides a good example (some tumours never secrete AFP and will therefore never be detected using an AFP-led approach and, equally, some tumours will infiltrate diffusely and resist US detection).